SYK.NYSEStryker CORP

Form 4: Stryker Corp CEO Kevin Lobo Granted Employee Stock Options

Sentiment:

SEC Form 4 Filing


Kevin Lobo, Chair and CEO of Stryker Corp, was granted employee stock options on February 5, 2025, exercisable over five years.

Summary

  • Kevin Lobo, the Chair and CEO of Stryker Corp, received employee stock options on February 5, 2025.
  • The options grant him the right to purchase 48,936 shares of Stryker common stock at an exercise price of $392.39 per share.
  • The options vest in five equal installments, with 20% becoming exercisable on each of the first five anniversaries of the grant date.
  • The options expire on February 4, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. The sentiment is neutral to slightly positive.

Positives

  • The granting of stock options to the CEO aligns his interests with those of the shareholders, incentivizing him to increase the company's value.
  • The vesting schedule encourages long-term commitment from the CEO.

Future Outlook

The document does not contain any specific forward-looking statements beyond the terms of the stock option grant.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, used to attract, retain, and incentivize top talent. Stryker is using a common compensation strategy.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in the medical device industry.
  • Companies like Medtronic, Johnson & Johnson, and Boston Scientific also utilize stock options as part of their executive compensation plans.
  • The vesting schedule of 20% per year over five years is a typical vesting arrangement.
  • The number of shares granted and the exercise price would need to be compared to similar grants at peer companies to determine if they are in line with industry standards.

Stakeholder Impact

  • Shareholders may view the stock option grant positively as it incentivizes the CEO to increase shareholder value.
  • Employees may see the grant as a sign of confidence in the company's future.

Key Dates

DateDescription
02/05/2025Date of employee stock option grant
02/05/2025First vesting date (20% of options)
02/04/2035Expiration date of the options

Keywords

Stryker, Kevin Lobo, Stock Options, Employee Stock Option, Incentive Plan, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.